High Blood Cholesterol Clinical Trial
Official title:
CEPHEUS Centralized Pan-Levant Survey on the Undertreatment of Hypercholesterolemia NIS-LT-CRE-2010/01 Version 1.0
This was a multicenter survey of patients who were on lipid -lowering pharmacological
treatment in 2 Levant countries namely Jordan and Lebanon. The purpose is to study the
effects of cholesterol lowering drugs on the blood cholesterol levels of patients in Jordan
and Lebanon.
Data collected from each patient took place at a single visit. Each participating doctor
filled the investigator questionnaire on his/her experience and perception of the management
of the hypercholesterolemia of his/her patients. Each doctor was asked to indicate his/her
general attitude on the diagnosis of hypercholesterolemia, the existing guidelines and goals
and the various treatment options for high cholesterol in blood.
Before being assessed by the investigator, patients recorded, on the patient questionnaire,
their awareness of high blood cholesterol , their current lipid-lowering treatment schedule,
their understanding of their condition and compliance in taking the medications on time.
The investigators completed a Patient Record Form (PRF) with the patient's basic
information, cardiovascular risk factors and the cardiovascular medical history, current
lipid lowering drug treatment and the reason for the current therapy.
A blood sample under fasting condition was drawn from each subject. A central laboratory in
Jordan received all samples. Every sample was analyzed for its cholesterol blood level,
fasting sugar level and hemoglobin A1C levels.
CEPHEUS Centralized Pan-Levant Survey on the Undertreatment of Hypercholesterolemia NIS-LT-CRE-2010/01 Version 1.0 ;
Observational Model: Case-Only, Time Perspective: Cross-Sectional